XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

Archive ouverte

Deczkowska, Aleksandra | David, Eyal | Ramadori, Pierluigi | Pfister, Dominik | Safran, Michael | At The, Baoguo | Giladi, Amir | Jaitin, Diego Adhemar | Barboy, Oren | Cohen, Merav | Yofe, Ido | Gur, Chamutal | Shlomi-Loubaton, Shir | Henri, Sandrine | Suhail, Yousuf | Qiu, Mengjie | Kam, Shing | Hermon, Hila | Lahat, Eylon | Ben Yakov, Gil | Cohen-Ezra, Oranit | Davidov, Yana | Likhter, Mariya | Goitein, David | Roth, Susanne | Weber, Achim | Malissen, Bernard | Weiner, Assaf | Ben-Ari, Ziv | Heikenwälder, Mathias | Elinav, Eran | Amit, Ido

Edité par CCSD ; Nature Publishing Group -

International audience. Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are prevalent liver conditions that underlie the development of life-threatening cirrhosis, liver failure and liver cancer. Chronic necro-inflammation is a critical factor in development of NASH, yet the cellular and molecular mechanisms of immune dysregulation in this disease are poorly understood. Here, using single-cell transcriptomic analysis, we comprehensively profiled the immune composition of the mouse liver during NASH. We identified a significant pathology-associated increase in hepatic conventional dendritic cells (cDCs) and further defined their source as NASH-induced boost in cycling of cDC progenitors in the bone marrow. Analysis of blood and liver from patients on the NAFLD/NASH spectrum showed that type 1 cDCs (cDC1) were more abundant and activated in disease. Sequencing of physically interacting cDC-T cell pairs from liver-draining lymph nodes revealed that cDCs in NASH promote inflammatory T cell reprogramming, previously associated with NASH worsening. Finally, depletion of cDC1 in XCR1DTA mice or using anti-XCL1-blocking antibody attenuated liver pathology in NASH mouse models. Overall, our study provides a comprehensive characterization of cDC biology in NASH and identifies XCR1+ cDC1 as an important driver of liver pathology.

Suggestions

Du même auteur

Publisher Correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis

Archive ouverte | Deczkowska, Aleksandra | CCSD

International audience. In the version of this Article initially published, an electronic conversion error led to errors in the names of Michal Safran and Baoguo Li. Their names have been corrected in the online ver...

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Archive ouverte | Pfister, Dominik | CCSD

International audience. Abstract Hepatocellular carcinoma (HCC) can have viral or non-viral causes 1–5 . Non-alcoholic steatohepatitis (NASH) is an important driver of HCC. Immunotherapy has been approved for treati...

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Archive ouverte | Pfister, Dominik | CCSD

International audience. Abstract Hepatocellular carcinoma (HCC) can have viral or non-viral causes 1–5 . Non-alcoholic steatohepatitis (NASH) is an important driver of HCC. Immunotherapy has been approved for treati...

Chargement des enrichissements...